Cargando…

Ambroxol for the treatment of COVID-19 among hospitalized patients: A multicenter retrospective cohort study

Ambroxol is a commonly used mucolytic agent principally used to treat respiratory diseases, which may have a role as adjunctive therapy for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but there is lack of evidence about its effectiveness on coronavirus disease-2019 (COVID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yun, Yang, Qing-qing, Zhuo, Lin, Yang, Kun, Kou, Hao, Gao, Su-yu, Hu, Wen, Jiang, Qiao-li, Li, Wen-jing, Wu, Dong-fang, Sun, Feng, Cheng, Hong, Zhan, Siyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582747/ https://www.ncbi.nlm.nih.gov/pubmed/36274736 http://dx.doi.org/10.3389/fmicb.2022.1013038

Ejemplares similares

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023)

Value of ambroxol in the treatment of asthmatic bronchitis
por: Du, Xiaoxia, et al.
Publicado: (2020)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis
por: CHEN, FENG, et al.
Publicado: (2015)

Ambroxol for the treatment of fibromyalgia: science or fiction?
por: Kern, Kai-Uwe, et al.
Publicado: (2017)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation
por: Takeda, Katsuyuki, et al.
Publicado: (2016)

Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study
por: Yuan, Qing, et al.
Publicado: (2023)

The protective effects of Ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats
por: Gao, Xiwen, et al.
Publicado: (2011)

Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis
por: Chenot, Jean-François, et al.
Publicado: (2014)

Ambroxol effects in glucocerebrosidase and α‐synuclein transgenic mice
por: Migdalska‐Richards, Anna, et al.
Publicado: (2016)

Evaluation of safety and efficacy of inhaled ambroxol in hospitalized adult patients with mucopurulent sputum and expectoration difficulty
por: Zheng, Zeguang, et al.
Publicado: (2023)

Study on the Efficacy and Safety of Ambroxol Combined with Methylprednisolone in Patients with Acute Lung Injury
por: Su, Weiwei, et al.
Publicado: (2021)

Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate
por: Migdalska‐Richards, Anna, et al.
Publicado: (2017)

Effectiveness and Safety of Lianhua Qingwen Capsules for COVID-19: A Propensity-Score Matched Cohort Study
por: Lu, Yun, et al.
Publicado: (2023)

Development and Validation of a Nomogram for the Prediction of Hospital Mortality of Patients With Encephalopathy Caused by Microbial Infection: A Retrospective Cohort Study
por: Zhao, Lina, et al.
Publicado: (2021)

Ambroxol: utilidad en la enfermedad de menbrana hiliana
por: Reyes Salazar, Gonzálo
Publicado: (1995)

Preparation and Evaluation of Microencapsulated Fast Melt Tablets of Ambroxol Hydrochloride
por: Jacob, S., et al.
Publicado: (2009)

Simultaneous UV Spectrophotometric Estimation of Ambroxol Hydrochloride and Levocetirizine Dihydrochloride
por: Prabhu, S. Lakshmana, et al.
Publicado: (2008)

Enhanced Controlled Transdermal Delivery of Ambroxol from the EVA Matrix
por: Cho, C. W., et al.
Publicado: (2012)

Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
por: Alkotaji, Myasar
Publicado: (2020)

Ambroxol Treatment Suppresses the Proliferation of Chlamydia pneumoniae in Murine Lungs
por: Kókai, Dávid, et al.
Publicado: (2021)

Does Ambroxol alleviate kidney ischemia-reperfusion injury in rats?
por: Gültekin, Çağrı, et al.
Publicado: (2022)

Corrigendum: Development and Validation of a Nomogram for the Prediction of Hospital Mortality of Patients With Encephalopathy Caused by Microbial Infection: A Retrospective Cohort Study
por: Zhao, Lina, et al.
Publicado: (2021)

Improvement of antioxidant activity and active ingredient of Dendrobium officinale via microbial fermentation
por: Yu, Gen, et al.
Publicado: (2023)

Corrigendum: Improvement of antioxidant activity and active ingredient of Dendrobium officinale via microbial fermentation
por: Yu, Gen, et al.
Publicado: (2023)

Association Between Ambroxol at the Usual Dose and the Risk of Parkinson’s Disease in Chronic Lung Disease
por: Kim, Min Seung, et al.
Publicado: (2023)

The effects of vaccination on the disease severity and factors for viral clearance and hospitalization in Omicron-infected patients: A retrospective observational cohort study from recent regional outbreaks in China
por: Li, Hongru, et al.
Publicado: (2022)

Different ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants
por: Zhou, Bin, et al.
Publicado: (2017)

Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
por: Narita, Aya, et al.
Publicado: (2016)

Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
por: Magalhaes, J., et al.
Publicado: (2018)

Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol
por: Heber, Sebastian, et al.
Publicado: (2022)

Mechanistic Insight into the Mode of Action of Acid β-Glucosidase Enhancer Ambroxol
por: Pantoom, Supansa, et al.
Publicado: (2022)

Ambroxol Improves Neuronal Survival and Reduces White Matter Damage through Suppressing Endoplasmic Reticulum Stress in Microglia after Intracerebral Hemorrhage
por: Jiang, Xuheng, et al.
Publicado: (2020)

Corrigendum to “Ambroxol Improves Neuronal Survival and Reduces White Matter Damage through Suppressing Endoplasmic Reticulum Stress in Microglia after Intracerebral Hemorrhage”
por: Jiang, Xuheng, et al.
Publicado: (2020)

Thiazolidinedione use is associated with reduced risk of dementia in patients with type 2 diabetes mellitus: A retrospective cohort study
por: Zhao, Houyu, et al.
Publicado: (2023)

Clinical characteristics and risk factors for in‐hospital mortality of lung cancer patients with COVID‐19: A multicenter, retrospective, cohort study
por: Nie, Lei, et al.
Publicado: (2020)

Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents
por: Gangurde, HH, et al.
Publicado: (2011)

Uso de ambroxol vs ventilación con enfermedad de membrana hialina
por: Ramírez Pérez, Manuel Adhiel
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_0k3cml8cfau61f3mm2gd06hr9o